These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12208864)

  • 1. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
    Signoretti S; Di Marcotullio L; Richardson A; Ramaswamy S; Isaac B; Rue M; Monti F; Loda M; Pagano M
    J Clin Invest; 2002 Sep; 110(5):633-41. PubMed ID: 12208864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy.
    Zheng WQ; Zheng JM; Ma R; Meng FF; Ni CR
    Steroids; 2005 Oct; 70(11):770-4. PubMed ID: 16024059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skp2 is oncogenic and overexpressed in human cancers.
    Gstaiger M; Jordan R; Lim M; Catzavelos C; Mestan J; Slingerland J; Krek W
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5043-8. PubMed ID: 11309491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
    Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
    Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer.
    Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A
    J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R; Wang TT; Miller WH; White JH
    Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.
    Slotky M; Shapira M; Ben-Izhak O; Linn S; Futerman B; Tsalic M; Hershko DD
    Breast Cancer Res; 2005; 7(5):R737-44. PubMed ID: 16168119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
    Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
    Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
    Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
    Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.
    Chiarle R; Fan Y; Piva R; Boggino H; Skolnik J; Novero D; Palestro G; De Wolf-Peeters C; Chilosi M; Pagano M; Inghirami G
    Am J Pathol; 2002 Apr; 160(4):1457-66. PubMed ID: 11943729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma.
    Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
    Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of the F-box proteins Skp2 and Skp2B in breast cancer.
    Radke S; Pirkmaier A; Germain D
    Oncogene; 2005 May; 24(21):3448-58. PubMed ID: 15782142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
    Huang HC; Way TD; Lin CL; Lin JK
    Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of beta 1-integrin-mediated hepatoma cell growth involves p27 and S-phase kinase-associated protein 2.
    Zhang H; Ozaki I; Mizuta T; Yoshimura T; Matsuhashi S; Hisatomi A; Tadano J; Sakai T; Yamamoto K
    Hepatology; 2003 Aug; 38(2):305-13. PubMed ID: 12883474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
    Lu Y; Zi X; Pollak M
    Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse relationship between p27/Kip.1 and the F-box protein Skp2 in human astrocytic gliomas by immunohistochemistry and Western blot.
    Schiffer D; Cavalla P; Fiano V; Ghimenti C; Piva R
    Neurosci Lett; 2002 Aug; 328(2):125-8. PubMed ID: 12133571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H; Wierenga AT; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.